Trials / Withdrawn
WithdrawnNCT04311541
A Study of Dexlansoprazole Modified Release (MR) in Gastroesophageal Reflux Disease (GERD) Participants in the Russian Federation
National, Multicentre, Observational, Non-Interventional Prospective Study of Dexlansoprazole MR in GERD Patients in the Russian Federation
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Takeda · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of the study is to evaluate effect of Dexilant treatment among GERD participants in the Russian Federation.
Detailed description
This is an observational, prospective non-interventional study of participants with GERD. This study will evaluate the effect of dexlansoprazole treatment among participants with GERD. The study will enroll approximately 1500 participants. Due to non-interventional design of the study, the decision about GERD treatment strategy for the participant is taken by attending treating physician. All participants will be enrolled in one observational group: dexlansoprazole. Prospective data will be collected for a period of 2 months. The frequency of the visits will be assigned by each physician according to their routine practice. The multi-center trial will be conducted in Russia. The overall duration of study will be approximately 2 months.
Conditions
Timeline
- Start date
- 2020-03-15
- Primary completion
- 2021-06-15
- Completion
- 2022-01-31
- First posted
- 2020-03-17
- Last updated
- 2020-04-14
Source: ClinicalTrials.gov record NCT04311541. Inclusion in this directory is not an endorsement.